Barclays Maintains Overweight on Intuitive Surgical, Raises Price Target to $385
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Matt Miksic maintains an Overweight rating on Intuitive Surgical (NASDAQ:ISRG) and raises the price target from $314 to $385.
July 24, 2023 | 11:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Overweight rating on Intuitive Surgical and raises the price target from $314 to $385, indicating a positive outlook for the company.
The raised price target by Barclays indicates their belief in the company's potential for growth. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100